Health Tech Forward

  • AI blood test could steer patients with pancreatic cancer away from ineffective therapies       

    An artificial intelligence technique for detecting DNA fragments shed by tumours and circulating in a patient’s blood could help clinicians more quickly identify and determine if pancreatic cancer therapies are working. After testing the method, called ARTEMIS-DELFI, in blood samples from patients participating in two large clinical trials of pancreatic cancer treatments, researchers found that [...]

  • ‘Amazon-style’ prescription tracking goes live in NHS App

    Millions of patients can now track their prescriptions following the rollout of a new feature in the NHS App helping to reduce unnecessary calls and visits to pharmacies. NHS England has announced that nearly 1,500 high street chemists – including every Boots in England – are now offering the service, which enables patients to check [...]

  • White Paper outlines how Managed Equipment Service can help tackle key challenges in NHS radiotherapy depts

    Ergéa UK, a vendor-neutral provider of Managed Equipment Services (MES), has published a comprehensive white paper exploring how modern MES solutions can help expand patient access to radiotherapy across the UK. Titled “Radiotherapy MES: A Planned Long-Term Solution to the UK Radiotherapy Crisis,” the paper outlines how a radiotherapy MES provides a structured, funded, and [...]

  • IT industry’s flagship charity regatta celebrates 25 years and £1.3 million raised

    The UK’s largest charity and IT networking sailing event, the Russell-Cooke Silicon Cup Regatta, is preparing to set sail again this September, celebrating its 25th anniversary of raising money in support of life-changing causes.  Since its inception, the event has raised over £1.3 million and attracted around 7,500 competitors, uniting the IT industry for two [...]

  • Biostate AI closes $12m to bring ‘Netflix model’ to molecular diagnostics

    AI and RNA sequencing company Biostate AI has announced the successful completion of a $12M Series A funding round, led by Accel. The funds will support the company’s mission to unlock affordable and integrated precision medicine, starting with RNA sequencing (RNAseq) services for US-based molecular research. The company’s immediate focus is revolutionising RNAseq accessibility and [...]

  • Final exhibition stands remaining for WHX Dubai 2026

    The Association of British HealthTech Industries (ABHI) has announced that only a handful of exhibition stands remain for WHX Dubai 2026, taking place 9–12 February at Dubai Exhibition Centre, Expo City Dubai. The 2025 edition attracted more than 70,000 attendees from 180 countries, bringing together an audience that included senior hospital practitioners, healthcare executives, manufacturers [...]

  • Cyberbullying linked to PTSD in children

    Cyberbullying should be considered an adverse childhood experience (ACE) – a category of childhood trauma linked to long-term emotional, psychological and physical harm, new research suggests. While many assume that only extreme forms of online harassment – like threats or identity-based attacks – can cause significant harm, the findings suggest that even less visible or [...]

  • Reorganisation, consolidation, and cuts: what are the implications for NHS IT?

    NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board met to consider the impact on health tech, and how suppliers can navigate the chaos. During the general election campaign, Labour said “another top-down reorganisation [...]

  • A quarter of UK adults lost in the mental health crisis, study finds

    New research released during Mental Health Awareness Week, has revealed the depth of the UK’s growing mental health crisis, with millions of adults revealing they are unable to access correct treatment, whilst others are left confused, frustrated, or with a prescription of antidepressants to offer short-term help. Findings show that more than 14 million UK [...]

  • MedTech companies Paxman and Dignitana announce merger

    Paxman’s recent public offer to acquire its competitor Dignitana has been accepted, signifying a historical milestone for the two companies and heralding the start of a brand-new chapter of working together to advance side effect management for cancer patients around the world. Paxman and Dignitana will now combine, creating a stronger, unified company - Paxman AB [...]